CD8A and neoplasm: Specially, on one hand, it improves the tumor immunosuppressive microenvironment by blocking M2 macrophage formation; on the other hand, it further enhances T cell-mediated tumor killing by relieving M2 macrophage-mediated suppression of CD8+ T cells.